CD44 and breast carcinoma: Previously, we found that in breast cancer, CTCs with phenotypes including co-expression of the epithelial marker CK7/8 and the stemness marker CD133, but not CD44+/CD24−, were more characterized by a lack of evidence of apoptosis.